Bioventus Inc. BVS
10.97 USD -2.18 -16.58%
As of Nov 3, 2:07 PM ET
- YTD
- +47.45%
- 1 year
- +67.23%
- Open
- 10.93
- Prev close
- 13.15
- Mkt cap
- 749.99M
- Vol
- 1.61M
- Avg vol
- 555.03K
- EPS
- 0.78
- P/E
- 14.08
- Div yield
- 0.00%
More statistics
- Low
- 10.09
- High
- 11.36
- Forward P/E
- 16.16
- Beta
- 0.64
- Short ratio
- 7.53
- Inst. own
- 84.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 13.72
- 200-d avg
- 10.84
- 1y target
- 17.60
5m chart
Chart tools
Chart is warming up
The five-minute interval price history for BVS has not been loaded yet. Try again in a moment.
Altman Z-Score
1.90 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 3
- P/B 2
P/E 21.9×
P/S 0.9×
P/B 2.7×
P/FCF 6.9×
EV/EBITDA 7.6×
EV/Sales 1.3×
FCF Yield 14.4%
Gross Margin 67.3%
Operating Margin 10.3%
Net Margin 4.0%
ROE 12.3%
ROIC 10.8%
ROA 3.3%
Revenue -0.9%
Operating Income 588.7%
EPS (diluted) 163.5%
Free Cash Flow 89.0%
Current Ratio 1.7×
Quick Ratio 1.2×
Debt / Equity 1.7×
Net Debt / EBITDA 2.6×
Interest Coverage 2.2×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31